Stay updated on Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a new site revision label Revision: v3.4.2, and removed the government funding status notice and the older Revision: v3.4.1.SummaryDifference0.4%

- Check21 days agoChange DetectedNotice about a lapse in government funding and current operating status added at the top with guidance to opm.gov; page revision updated from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedShow glossary feature added; capitalization updated for 'Last Update Submitted that Met QC Criteria'; and new labels 'No FEAR Act Data' and 'Revision: v3.4.0' appear on the page. These are minor UI/label and versioning changes that do not alter core study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4. This appears to be a minor documentation/version update with no apparent impact on study details or user actions.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a Locations section with Washington as a study location and removed the prior Washington Locations item. Also updated the page revision from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check85 days agoChange DetectedPage shows a minor version update from v3.3.1 to v3.3.2; no changes to study details, layout, or user-facing content are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page.